Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
HER2 status as a potential predictive biomarker for ovarian clear cell carcinoma.
Kendall Bártů M, Němejcová K, Michálková R, Stružinská I, Hájková N, Hojný J, Krkavcová E, Laco J, Matěj R, Drozenová J, Méhes G, Fabian P, Hausnerová J, Švajdler M, Škapa P, Cibula D, Zima T, Dundr P. Kendall Bártů M, et al. Among authors: michalkova r. Virchows Arch. 2023 Oct;483(4):497-507. doi: 10.1007/s00428-023-03640-4. Epub 2023 Sep 7. Virchows Arch. 2023. PMID: 37676270
Uterine cellular leiomyomas are characterized by common HMGA2 aberrations, followed by chromosome 1p deletion and MED12 mutation: morphological, molecular, and immunohistochemical study of 52 cases.
Dundr P, Gregová M, Hojný J, Krkavcová E, Michálková R, Němejcová K, Bártů M, Hájková N, Laco J, Mára M, Richtárová A, Zima T, Stružinská I. Dundr P, et al. Among authors: michalkova r. Virchows Arch. 2022 Feb;480(2):281-291. doi: 10.1007/s00428-021-03217-z. Epub 2021 Oct 9. Virchows Arch. 2022. PMID: 34626221
The cytokeratin 17 expression in primary ovarian tumors has diagnostic but not prognostic significance.
Dundr P, Bazalová B, Bártů M, Bosse T, Drozenová J, Fabian P, Fadare O, Hausnerová J, Jakša R, Laco J, Lax SF, Matěj R, McCluggage WG, Méhes G, Michálková R, Němejcová K, Singh N, Stolnicu S, Škapa P, Švajdler M, Stružinská I. Dundr P, et al. Among authors: michalkova r. Virchows Arch. 2022 Aug;481(2):201-212. doi: 10.1007/s00428-022-03338-z. Epub 2022 May 13. Virchows Arch. 2022. PMID: 35554675
A comprehensive molecular analysis of 113 primary ovarian clear cell carcinomas reveals common therapeutically significant aberrations.
Stružinská I, Hájková N, Hojný J, Krkavcová E, Michálková R, Dvořák J, Němejcová K, Matěj R, Laco J, Drozenová J, Fabian P, Hausnerová J, Méhes G, Škapa P, Švajdler M, Cibula D, Frühauf F, Bártů MK, Dundr P. Stružinská I, et al. Among authors: michalkova r. Diagn Pathol. 2023 Jun 12;18(1):72. doi: 10.1186/s13000-023-01358-0. Diagn Pathol. 2023. PMID: 37303048 Free PMC article.
Refined criteria for p53 expression in ovarian mucinous tumours are highly concordant with TP53 mutation status, but p53 expression/TP53 status lack prognostic significance.
Dundr P, Hájková N, Kendall Bártů M, Cibula D, Drozenová J, Fabian P, Fadare O, Frühauf F, Hausnerová J, Hojný J, Laco J, Lax SF, Matěj R, Méhes G, Michálková R, Němejcová K, Singh N, Stolnicu S, Švajdler M, Zima T, McCluggage WG, Stružinská I. Dundr P, et al. Among authors: michalkova r. Pathology. 2023 Oct;55(6):785-791. doi: 10.1016/j.pathol.2023.04.008. Epub 2023 Jul 11. Pathology. 2023. PMID: 37500307
Immunohistochemical expression of PRAME in 485 cases of epithelial tubo-ovarian tumors.
Šafanda A, Kendall Bártů M, Michálková R, Stružinská I, Drozenová J, Fabián P, Hausnerová J, Laco J, Matěj R, Škapa P, Švajdler M, Špůrková Z, Méhes G, Dundr P, Němejcová K. Šafanda A, et al. Among authors: michalkova r. Virchows Arch. 2023 Oct;483(4):509-516. doi: 10.1007/s00428-023-03629-z. Epub 2023 Aug 23. Virchows Arch. 2023. PMID: 37610627
Synchronous endometrioid endometrial and ovarian carcinomas are biologically related: A clinico-pathological and molecular (next generation sequencing) study of 22 cases.
Hájková N, Tichá I, Hojný J, Němejcová K, Bártů M, Michálková R, Zikán M, Cibula D, Laco J, Geryk T, Méhes G, Dundr P. Hájková N, et al. Among authors: michalkova r. Oncol Lett. 2019 Feb;17(2):2207-2214. doi: 10.3892/ol.2018.9855. Epub 2018 Dec 20. Oncol Lett. 2019. PMID: 30675285 Free PMC article.
A comprehensive analysis of the expression, epigenetic and genetic changes of HNF1B and ECI2 in 122 cases of high-grade serous ovarian carcinoma.
Němejcová K, Bártů M, Hojný J, Hájková N, Michálková R, Krkavcová E, Stružinská I, Bui HQ, Dundr P, Cibula D, Jirsová K. Němejcová K, et al. Among authors: michalkova r. Oncol Lett. 2021 Mar;21(3):185. doi: 10.3892/ol.2021.12446. Epub 2021 Jan 6. Oncol Lett. 2021. PMID: 33574924 Free PMC article.
A comprehensive immunohistochemical analysis of IMP2 and IMP3 in 542 cases of ovarian tumors.
Němejcová K, Bártů MK, Michálková R, Drozenová J, Fabian P, Fadare O, Hausnerová J, Laco J, Matěj R, Méhes G, Singh N, Stolnicu S, Škapa P, Švajdler M, Stružinská I, Cibula D, Kocian R, Lax SF, McCluggage WG, Dundr P. Němejcová K, et al. Among authors: michalkova r. Diagn Pathol. 2023 Feb 6;18(1):15. doi: 10.1186/s13000-023-01300-4. Diagn Pathol. 2023. PMID: 36740684 Free PMC article.
36 results